Functional Living Index - Emesis (FLIE)

Lindley C

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

Developed in 1992

Authors

Lindley C

Copyright
© Copyright 1992 Celeste Lindley. All Rights Reserved.
Objective
To assess the impact of chemotherapy-induced nausea and vomiting on patient's daily function
Therapeutic area
  • Neoplasms
Therapeutic indication

Generic for Neoplasms

Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire

Lindley CM, Hirsch JD, O'Neill CV, Transau MC, Gilbert CS, Osterhaus JT. Quality of life consequences of chemotherapy-induced emesis. Qual Life Res. 1992 Oct;1(5):331-40 (PubMed abstract)


Contact and conditions of use

Authors

Lindley C

107 Beachwood drive
Pine Knoll Shores, NC 28512
USA
E-mail: celeste.lindley@gmail.com

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Access fees

ROYALTY FEES* Commercial users Cost per study 1100 €
Cost per language 550 €
Funded academic research Cost per study Free
Cost per language Free
Not funded academic users Cost per study Free
Cost per language Free
DISTRIBUTION FEES* Commercial users Cost per study 1000 €
Cost per language 500 €
Funded academic research Cost per study 300 €
Cost per language 50 €
Not funded academic users Cost per study Free
Cost per language Free

* Excluding VAT
Commercial users: Industry, CRO, any for-profit companies
Funded Academic research: Projects receiving funding from commerce, government, EU or registered charity. Funded academic research– sponsored by industry fits the “commercial users” category.
Not funded academic users, individual medical practice: Projects are not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds

Conditions to translate

Please refer to the "Languages" tab

Conditions to implement in electronic applications

Exclusive licensor for e-versions of the questionnaireMapi Research Trust

Academic and Commercial Users
  • Shall follow the “Conditions of use”  mentioned above
  • In addition, in case the electronic version of the questionnaire is developed by a third party (IT Company, e-PRO vendor…), User shall check with Mapi Research Trust that this third party has signed the necessary License Agreement with Mapi Research Trust before developing the electronic version of the Questionnaire.

Information Technology (IT) Companies (incl. ePRO vendors)
  • In case of a one-shot development and commercial use of an electronic version of the questionnaire by the IT Company, the IT Company shall:
    • Sign a “Specific-Study License Agreement with IT Company” with Mapi Research Trust
      • authorizing the electronic implementation of the questionnaire for the specific study only
      • shall not permit the IT Company to promote the electronic version of the questionnaire or its use for another study or another client
    • Pay a one-shot license fee per study to Mapi Research Trust: 500 Euros
  • In case of an IT Company who wishes to develop an electronic version of the questionnaire and would like to obtain a non-exclusive license to market and promote their devices / tablets / smartphones / e-applications using the questionnaire, the IT Company shall:
    • Sign a “General License Agreement with IT Company” with Mapi Research Trust
      • authorizing the electronic implementation of the questionnaire on multiple devices for multiple studies and clients
      • permitting the IT Company to promote the electronic versions of the questionnaire by any marketing means (including, but not limited to, IT Company’s  promotional documents / websites / press release / communication during conferences / webinars)
    • Pay an annual administrative fee of 2,500 Euros to Mapi Research Trust
    • Pay an annual royalty fee of 2,500 Euros to the author(s)

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Also available in:

Lindley CM, Hirsch JD, O'Neill CV, Transau MC, Gilbert CS, Osterhaus JT. Quality of life consequences of chemotherapy-induced emesis. Qual Life Res. 1992 Oct;1(5):331-40 (PubMed abstract)

Languages

Original language(s)

  • English for the USA

Translations

The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

FLIE

Afrikaans for South Africa*
Arabic for Egypt*
Bulgarian for Bulgaria*
Cantonese for Hong Kong*
Cebuano for the Philippines*
Croatian for Croatia*
Czech for Czech Republic*
Danish for Denmark*
Dutch for Belgium (Flemish)*
Dutch for the Netherlands*
English for Australia*
English for Canada*
English for Hong Kong
English for India*
English for New Zealand
English for South Africa*
English for the UK*
Estonian for Estonia*
Finnish for Finland*
French for Belgium*
French for Canada*
French for France*
French for Switzerland*
Georgian for Georgia*
German for Austria*
German for Germany*
German for Switzerland*
Greek for Greece*
Gujarati for India*
Hindi for India*
Hungarian for Hungary*
Ilocano for the Philippines*
Italian for Italy*
Italian for Switzerland
Japanese for Japan
Kannada for India*
Korean for Korea*
Korean for the USA*
Latvian for Latvia*
Lithuanian for Lithuania*
Malay*
Malay for Singapore*
Malayalam*
Mandarin for China*
Mandarin for Singapore*
Mandarin for Taiwan*
Marathi for India*
Norwegian for Norway*
Polish for Poland*
Portuguese for Brazil*
Portuguese for Portugal*
Romanian for Romania*
Russian for Belarus*
Russian for Latvia*
Russian for Russia*
Russian for Ukraine*
Slovak for Slovakia*
Slovenian for Slovenia*
Spanish for Argentina*
Spanish for Chile*
Spanish for Colombia*
Spanish for Costa Rica*
Spanish for Ecuador*
Spanish for Guatemala*
Spanish for Mexico*
Spanish for Peru*
Spanish for Spain*
Spanish for Venezuela*
Spanish for the USA*
Swedish for Finland*
Swedish for Sweden*
Tagalog for the Philippines*
Tamil for India*
Telugu for India*
Thai for Thailand*
Turkish for Turkey*
Ukrainian for Ukraine*
Urdu*
Urdu for India*
Vietnamese for Vietnam*
* Performed by Mapi

The author has selected Mapi as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

More information on translations


 For information on, or permission to use the translations, please contact:Ralph H Raasch

 Bibliographic reference of the 22 translations performed by Mapi Research Institute:

Giroudet C, Conway K, Martin A, Pearson J, Lindley C. Linguistic Validation of 5-day version of the Functional Living Index-Emesis into 22 languages. Supportive Care in Cancer. 2000; 8(3):241. (Abstract)
Presented at the 12th international symposium supportive care in cancer, Washington, USA, March 2000


 Bibliographic reference of the Japanese translation:

Satou A, Yamazaki T, Nukariya N, Nakamachi M, Shimada K, Matsukawa M, Kurihara M. [Development of a Japanese version of the FLIE] Gan To Kagaku Ryoho. 2002 Feb;29(2):281-91. Japanese

Online distribution

My study is not funded

  • I am a non-commercial user
  • I do not receive specific funding for my study
  • I intend to use the questionnaire in individual clinical practice or research study
Login SIGN up free

My study is funded

If your study is funded, or if you haven't found your translation in the Languages menu, please submit your request online.

Our team will get back to you as soon as possible.

Member Access

Subscribe to PROQOLID to access to full informations

And get access to advanced descriptions of Clinical Outcome Assessments (COAs)!

A question ? Contact us